IMIDomics, a Vall d'Hebron spin-off, raises $16.5 million to develop new drugs against immunomediated inflammatory diseases

by Vall d’Hebron

This investment will allow IMIDomics to accelerate the identification of new therapeutic targets and the development of new drugs for immune-mediated inflammatory diseases (IMID), like rheumatoid arth...

Read more

Revisiting the role of Extracellular Vesicles secreted by hepatocytes in drug-induced liver injury. A PRO-EURO-DILI-NETWORK Cost Action outcome

by CIC bioGUNE

Idiosyncratic drug-induced liver injury (DILI) constitutes a multi-layered challenge that spans the life of the drug from pre-clinical development to clinical trials and post-marketing.

Read more

CSIC Scientists propose a new strategy to regulate the cells communication network

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

A study performed by researchers at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) from the Spanish National Research Council (CSIC) in collaboration with Stony Brook University (USA) p...

Read more

Comparison between 2D and 3D Cultures

by CYTES BIOTECHNOLOGIES, SL.

Within the pharmaceutical industry, business firms and organizations need to test the toxicity of the drugs they create. The common method used is in vitro testing employing Primary Human Hepatocytes ...

Read more

Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder

by Vall d’Hebron

These findings open the way for research into new therapeutic targets, as well as for the study of the possibility of reusing drugs that are already used in other illnesses for the treatment of bipola...

Read more

Avacopan as a substitute for corticosteroids in the treatment of ANCA-associated vasculitis

by Fundació Clínic per a la Recerca Biomèdica

Vasculitis is a group of rare autoimmune diseases that, until now, have mainly been treated with corticosteroids and other immunosuppressants. Corticosteroids are effective, but they have many potenti...

Read more

Drugs approved by the FDA in 2020 reflect continuing trend of structural innovation

by CAS, a division of the American Chemical Society

New drug innovation remained strong in 2020. The total of 53 drugs approved represented the second-highest number of approvals in more than two decades, a positive indicator of productivity in the pha...

Read more

Research is the main tool we have against cancer

by GENESIS Biomed

Cancer is the second biggest cause of death throughout the world today. Every year 9.6 million people die from it, 65% of them in low- and medium-income countries. Spain shows a similar trend to other...

Read more

Researchers describe molecular mechanism involved in Huntington's neurodegeneration

by Universitat de Barcelona

Protein alteration in the family of lamins causes several diseases, known as laminopathies, such as progeria or precocious ageing.

Read more

The AECC funds research into new treatment for prostate cancer

by IRB Barcelona - Instituto de Investigación Biomédica

One in eight men will be diagnosed with prostate cancer at some point in their lifetime. Several treatments for this type of cancer are currently available, but the tumour develops resistance and the ...

Read more

Researcher Ramon Eritja publishes book about nucleic acids chemistry

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

The book “Nucleic Acids Chemistry” takes the most important aspects of the methodology of oligonucleotides synthesis, that is currently expanding by the endorsement of a dozen of new medicines, su...

Read more

Almirall and Tyris Therapeutics join forces to develop gene therapies

by CataloniaBio

Pharmaceutical company Almirall, a CataloniaBio & HealthTech member, and biotechnology firm Tyris Therapeutics have announced a new alliance to develop non-viral gene therapies to treat minority derma...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

ORYZON reports results and corporate upd...

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage...

Photos Stream